SCIENTIFIC BASIS AND THERAPEUTIC REGIMENS FOR USE OF ANTENATAL GLUCOCORTICOIDS
SCIENTIFIC BASIS AND THERAPEUTIC REGIMENS FOR USE OF ANTENATAL GLUCOCORTICOIDS
复制标题
DOI：
10.1016/0002-9378(95)90210-4
复制
发表时间：
1995-07-01
影响因子：
9.8
通讯作者：
BALLARD, RA
中科院分区：
文献类型：
--
作者：
BALLARD, PL;BALLARD, RA
美国国立卫生研究院关于皮质类固醇对胎儿成熟的影响的共识发展会议的报告是在Liggins的开创性观察25年后发布的。(1)在此期间，人们对皮质类固醇在发育中的肺和其他组织的作用和机制有了很多了解，产前类固醇治疗已经成为许多医学界的标准做法。在这篇综述中，我们总结了为产前治疗和推荐的皮质类固醇剂量提供科学依据的证据。
The report of the National Institutes of Health Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation comes 25 years after the pioneering observations of Liggins.(1) In that interval much has been learned about effects and mechanisms of corticosteroids in developing lung and other tissues, and prenatal steroid therapy has become standard practice in many medical communities. In this review we summarize the evidence that provides the scientific rationale for antenatal treatment and the recommended doses of corticosteroids.